Andrew Badrot, Founder of CMS Pharma kindly shared his thoughts on the Pharma M&A market, the challenges being faced and what companies can do to overcome the hurdles.
The Pharma Mergers and Acquisitions market has recently seen a lot of traffic, with deals between GlaxoSmithKline and Novartis, whilst Pfizer has made overtures to AstraZeneca. With activity on the up, it would appear that the M&A market is once again healthy and could potentially reach record values this year.
The report goes on to explore:
- The challenges Pharma M&A is facing
- What the current global market outlook is
- What role biotech and specialty pharma companies play in M&A
- An additional opinion piece from Andrew about the recent M&A developments
…And much more!
To learn more about the topics above download a copy today!
Andrew will be participating at the upcoming Pharma M&A Briefing on 10th June in London.